Channa.id – The Seaweed Investment and Forum Festival (SIFFEST) was once again held by the Ministry of Marine Affairs and Fisheries of the Republic of Indonesia (KKP) on 1–2 November 2022 at the JW Marriott Hotel Ballroom, Surabaya. As one of the invited participants, PT Mega Medica Pharmaceuticals (MMP) attended and took part in the …
Channa.id – The inaugural Seaweed Fest 2021 showcased various innovative and creative products developed from seaweed-based raw materials. The event was organized by the Ministry of Marine Affairs and Fisheries (KKP) of the Republic of Indonesia. At this official event, many unique products from selected local producers were presented, one of which was developed by …
Channa.id – Innovations in developing food-based solutions to address the issue of stunting or chronic malnutrition in Serdang Bedagai Regency (Sergai), North Sumatra, have shown promising progress. This stunting prevention initiative is carried out by providing additional nutritional intake in the form of capsules or syrup made from snakehead fish cultivation. As part of its …
Channa.id – PT Mega Medica Pharmaceuticals (MMP) and Universitas Sumatera Utara (USU) have reaffirmed their commitment to supporting the independence and resilience of the pharmaceutical industry. Their participation was marked by a special invitation from the Directorate General of Pharmaceuticals and Medical Devices, Ministry of Health of the Republic of Indonesia, to attend the National …
Channa.id – Ministry for Maritime Affairs and Investment (Kemenko Marves) has expressed its appreciation to the Serdang Bedagai Regency Government (Sergai) and industry partner PT Mega Medica Pharmaceuticals for their initiatives in developing and cultivating snakehead fish (Channa striata). This local product has not only boosted the reputation of Sergai at the national level but …
Channa.id – The Ministry of Research and Technology / National Research and Innovation Agency (RISTEK/BRIN) officially announced the results of the second phase of the research consortium and innovation program for accelerating the handling of Coronavirus Disease-19 (Covid-19) on July 6, 2020. From a total of 902 research proposals submitted by various universities and research …
As COVID-19 pandemic is still increasingly spreading in Indonesia, PT Mega Medica Pharmaceuticals (MMP) has responded and aims to giving meaningful contribution by donating its flagship immunomodulatory supplement products, Channa and Striatamin, to medical staffs in various hospitals throughout Indonesia. It is expected that the donation can help to maintain the immunity of medical staffs …
Donation of PT MMP to Several Hospitals in Indonesia for COVID-19 PreventionRead More »
Per June 2020, Channa, one of the flagship products from PT Mega Medica Pharmaceuticals (MMP), has received a Certificate of Standardized Herbal Medicine (Obat Herbal Terstandar/OHT) from the Indonesian Food and Drug Authority (Badan Pengawas Obat dan Makanan / BPOM). This also concludes Channa as the only one OHT in a capsule form from Snakehead fish …
Channa: The Only OHT of Snakehead Fish Extract in a Capsule FormRead More »
Following a collaboration plan that was initiated in the previous meeting on 11 January 2020, PT Mega Medica Pharmaceuticals (MMP) and the Serdang Bedagai Health Service (Sergai Health Office) signed a Memorandum of Understanding (MOU) on Thursday, 13 February 2020 at Garuda Restaurant, Medan. On this occasion, both parties agreed to start a collaborative research …
Initiated by a discussion conducted in early January 2020 between Mr. Guntur Berlian, M.Si, the Scientific Affairs Manager of PT Mega Medica Pharmaceuticals (MMP) and Dr. rer medic. dr. M. Ihwan, M.Sc from the Faculty of Medicine (FK) of the University of North Sumatra (USU), a research collaboration plan between MMP and FK USU has …
The Signing of Research Collaboration Agreement between PT MMP and FK USURead More »